CLINICAL_TRIALS
trial_result
· 2008-03-04
Clinical Trial Update: Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy [Phase 2]
Summary
A Phase 2 randomized trial comparing methotrexate alone versus methotrexate plus subcutaneous fludarabine in severe rheumatoid arthritis to assess safety, toler…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Arthritis, Rheumatoid, Synovitis | Phase 2 | Status: COMPLETED